Adar1 Capital Management, LLC Glycomimetics Inc Transaction History
Adar1 Capital Management, LLC
- $615 Billion
- Q3 2024
A detailed history of Adar1 Capital Management, LLC transactions in Glycomimetics Inc stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 45,700 shares of GLYC stock, worth $10,511. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,700
Previous 135,000
66.15%
Holding current value
$10,511
Previous $38 Million
79.68%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding GLYC
# of Institutions
36Shares Held
17.8MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA9.54MShares$2.2 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$614,1470.0% of portfolio
-
Siren, L.L.C. New York, NY1.97MShares$451,9760.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny781KShares$179,6530.0% of portfolio
-
Black Rock Inc. New York, NY723KShares$166,3320.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $12.1M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...